CLU and Alzheimer disease: Plasma levels of proteins including clusterin, fetuin B, pancreatic prohormone, and prostate-specific antigen complexed to α1-antichymotrypsin are altered during AD and can be analyzed as good biomarkers but only together represent a reliable tool for diagnosis with strong correlation to AD [2].